SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,924.68 -547.65
( -0.76%)

Global Indices

Nasdaq

51,671.07 418.43
(0.82%)

Dow Jones

7,831.57 45.21
(0.58%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.78 0.11
(0.12%)

EUR-INR

108.39 0.07
(0.07%)

GBP-INR

127.86 0.00
(0.00%)

JPY-INR

0.61 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

108.6464045

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

59.13

6853.53

EPS(TTM)

Face Value()

Div & Yield %

10.9

0.15

Back

take ltd

Lords Mark Industries reports consolidated net profit of Rs 33.18 crore in the June 2026 quarter

Aug 13,2026

Net profit of Lords Mark Industries reported to Rs 33.18 crore in the quarter ended June 2026 as against net loss of Rs 0.03 crore during the previous quarter ended June 2025. Sales reported to Rs 307.68 crore in the quarter ended June 2026. There were no Sales reported during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	307.68	0	0
OPM %	15.98	0	-
PBDT	47.91	-0.03	LP
PBT	45.47	-0.03	LP
NP	33.18	-0.03	LP

71,924.68 -547.65 ( -0.76%)

51,671.07 418.43 (0.82%)

7,831.57 45.21 (0.58%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.78 0.11 (0.12%)

108.39 0.07 (0.07%)

127.86 0.00 (0.00%)

0.61 0.00 (0.21%)